This image provided by GlaxoSmithKline shows the company's Shingrix vaccine. On Oct. 20, 2017, the Food and Drug Administration approved the vaccine to prevent painful shingles in people aged 50 or older. It is the second vaccine for shingles, which is caused by the chickenpox virus. Merck has sold a shingles vaccine for about a decade.
This image provided by GlaxoSmithKline shows the company's Shingrix vaccine. On Oct. 20, 2017, the Food and Drug Administration approved the vaccine to prevent painful shingles in people aged 50 or older. It is the second vaccine for shingles, which is caused by the chickenpox virus. Merck has sold a shingles vaccine for about a decade. AP
This image provided by GlaxoSmithKline shows the company's Shingrix vaccine. On Oct. 20, 2017, the Food and Drug Administration approved the vaccine to prevent painful shingles in people aged 50 or older. It is the second vaccine for shingles, which is caused by the chickenpox virus. Merck has sold a shingles vaccine for about a decade. AP

GSK’s new shingles vaccine gets CDC panel’s endorsement. Should you get it?

October 25, 2017 11:10 AM